Profile data is unavailable for this security.
About the company
Inhalation Sciences Sweden AB is a Sweden-based company, which develops and sells labtech equipment for inhalation research. The Company’s primary product is PreciseInhale, which is a laboratory system that lets scientists measure how inhaled particles act in lungs and affect human health. PreciseInhale is a dry powder aerosol research and development system, which generate aerosols and data of a quality. The system helps to eliminate poor candidate drugs before clinical trials. The secondary product is LaminarPace, a tool for drying small amounts of drug substance. The Company’s customers comprise Dow Chemical Group, Kings College London and Karolinska Institutet, among others. The Company’s main shareholder is Nordnet Pensionsforsakring.
- Revenue in SEK (TTM)3.24m
- Net income in SEK-9.93m
- Incorporated2004
- Employees6.00
- LocationInhalation Sciences Sweden ABHalsovagen 7, Novum Floor 6, Elevator EHUDDINGE 141 57SwedenSWE
- Phone+46 85 468845846
- Websitehttps://www.inhalation.se/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bio Vitos Pharma AB | 191.53k | -20.07m | 4.73m | 1.00 | -- | 0.297 | -- | 24.69 | -0.4841 | -0.4841 | 0.005 | 0.4041 | 0.0076 | 0.0942 | 0.299 | 191,530.00 | -79.90 | -44.87 | -82.20 | -47.26 | -1,131.93 | 225.59 | -10,478.24 | -1,255.50 | 0.5737 | -- | 0.00 | -- | -96.31 | -- | -55.97 | -- | -- | -- |
| Servana AB (publ) | 1.35m | -8.31m | 8.04m | 5.00 | -- | 13.79 | -- | 5.93 | -0.0046 | -0.0046 | 0.0008 | 0.0003 | 0.1974 | -- | 1.69 | 270,958.00 | -121.07 | -88.75 | -164.36 | -105.56 | 18.01 | 20.89 | -613.44 | -610.25 | -- | -- | 0.00 | -- | 32.91 | 32.89 | -4.06 | -- | 2.96 | -- |
| S2Medical AB (publ) | 18.87m | -996.45k | 8.81m | 17.00 | -- | 0.4382 | 25.19 | 0.4668 | -0.0012 | -0.0012 | 0.0224 | 0.0224 | 0.8658 | 0.516 | 12.92 | -- | -4.57 | -56.60 | -6.87 | -104.62 | 95.30 | 69.19 | -5.28 | -138.46 | 0.5176 | -39.17 | 0.00 | -- | 110.53 | 36.49 | 121.19 | -- | -- | -- |
| Inhalation Sciences Sweden AB | 3.24m | -9.93m | 12.53m | 6.00 | -- | 1.27 | -- | 3.87 | -0.4092 | -0.4092 | 0.1154 | 0.2529 | 0.2597 | 0.1161 | 3.10 | 539,666.70 | -79.64 | -30.98 | -98.54 | -45.83 | 89.22 | 75.78 | -306.67 | -47.68 | 4.70 | -521.63 | 0.003 | -- | -36.89 | 4.30 | -8.49 | -- | -- | -- |
| Level Bio AB (publ) | 32.36m | -3.54m | 21.81m | 10.00 | -- | 36.94 | -- | 0.6739 | -0.0506 | -0.0506 | 0.4663 | 0.0093 | 2.20 | 5.28 | 5.57 | 3,236,100.00 | -24.07 | -16.73 | -125.44 | -28.43 | 38.12 | -- | -10.94 | -11.02 | 0.6872 | -43.60 | 0.3467 | -- | 28.95 | 6.42 | 55.04 | -- | -- | -- |
| SensoDetect AB | 1.31m | -9.49m | 25.38m | 2.00 | -- | 1.57 | -- | 19.32 | -0.0249 | -0.0249 | 0.0033 | 0.0366 | 0.0944 | -11.78 | 1,314.00 | 657,000.00 | -68.15 | -- | -79.20 | -- | 160.50 | -- | -722.22 | -- | 2.60 | -315.33 | 0.00 | -- | 375.00 | -- | -17.81 | -- | -- | -- |
| VibroSense Dynamics AB | 1.96m | -5.35m | 26.21m | -- | -- | 3.55 | -- | 13.37 | -0.1714 | -0.1714 | 0.0624 | 0.2253 | 0.182 | 0.0498 | 12.21 | -- | -49.70 | -- | -58.55 | -- | 97.92 | -- | -273.12 | -- | 5.05 | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- |
| Invent Medic Sweden AB | 7.40m | -5.20m | 29.97m | 7.00 | -- | 5.57 | -- | 4.05 | -0.0506 | -0.0506 | 0.0704 | 0.0486 | 0.7371 | 2.58 | 4.14 | 1,057,714.00 | -51.77 | -80.18 | -83.44 | -108.23 | 78.21 | 77.97 | -70.23 | -198.10 | 0.9586 | -17.71 | -- | -- | 0.7974 | 37.31 | 32.03 | -- | -- | -- |
| Perpetua Medical AB (publ) | 13.57m | 3.96m | 31.23m | 11.00 | 4.17 | 4.18 | 5.77 | 2.30 | 0.8754 | 0.8754 | 3.00 | 0.8731 | 0.4046 | 13.04 | 3.87 | 4,522,697.00 | 11.65 | -71.55 | 19.36 | -91.64 | 4.34 | -49.08 | 28.80 | -180.67 | 2.28 | 8.72 | 0.4216 | -- | -30.16 | 26.04 | 86.47 | -- | -32.00 | -- |
| NanoEcho AB (publ) | 488.00k | -15.65m | 31.71m | 6.00 | -- | 0.9324 | -- | 64.98 | -0.0576 | -0.0576 | 0.0017 | 0.0484 | 0.0189 | -- | 0.2746 | 81,333.34 | -60.59 | -58.24 | -94.28 | -72.68 | 100.00 | 1,011.05 | -3,207.79 | -15,690.63 | -- | -17.08 | 0.00 | -- | -- | -- | -3.35 | -- | -10.37 | -- |
| Codelab Capital AS | -95.60bn | -95.60bn | 36.21m | 28.00 | -- | 1.17 | -- | -- | -- | -- | -- | 2.25 | -- | -- | -- | -- | -- | -10.24 | -- | -11.34 | -- | 83.77 | -- | -64.81 | -- | -- | 0.00 | -- | -99.58 | -70.67 | -602.25 | -- | -22.77 | -- |
| Luxbright AB | 11.49m | -19.25m | 46.85m | 12.00 | -- | 1.74 | -- | 4.08 | -0.1644 | -0.1644 | 0.0968 | 0.2067 | 0.2788 | 7.73 | 2.68 | -- | -46.74 | -56.30 | -59.61 | -66.28 | -6.22 | -79.12 | -167.60 | -450.36 | 1.22 | -83.81 | 0.1076 | -- | 26.52 | 79.40 | -9.86 | -- | -- | -- |
Data as of Mar 02 2026. Currency figures normalised to Inhalation Sciences Sweden AB's reporting currency: Swedish Krona SEK
